Rice Hall James & Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $317K | Sell |
5,768
-112
| -2% | -$6.16K | 0.02% | 238 |
|
|
2025
Q1 | $416K | Buy |
5,880
+89
| +2% | +$6.29K | 0.02% | 230 |
|
|
2024
Q4 | $381K | Sell |
5,791
-4,536
| -44% | -$298K | 0.02% | 238 |
|
|
2024
Q3 | $726K | Sell |
10,327
-10,352
| -50% | -$728K | 0.04% | 214 |
|
|
2024
Q2 | $1.7M | Sell |
20,679
-8,043
| -28% | -$662K | 0.1% | 174 |
|
|
2024
Q1 | $2.51M | Sell |
28,722
-692
| -2% | -$60.4K | 0.14% | 149 |
|
|
2023
Q4 | $2.84M | Sell |
29,414
-1,453
| -5% | -$140K | 0.16% | 134 |
|
|
2023
Q3 | $2.73M | Sell |
30,867
-1,818
| -6% | -$161K | 0.17% | 133 |
|
|
2023
Q2 | $2.83M | Sell |
32,685
-1,354
| -4% | -$117K | 0.16% | 143 |
|
|
2023
Q1 | $3.31M | Sell |
34,039
-369
| -1% | -$35.9K | 0.19% | 132 |
|
|
2022
Q4 | $3.56M | Buy |
34,408
+13,377
| +64% | +$1.38M | 0.2% | 119 |
|
|
2022
Q3 | $1.78M | Sell |
21,031
-28,972
| -58% | -$2.46M | 0.1% | 197 |
|
|
2022
Q2 | $4.14M | Sell |
50,003
-9,467
| -16% | -$785K | 0.2% | 103 |
|
|
2022
Q1 | $4.59M | Sell |
59,470
-2,053
| -3% | -$158K | 0.18% | 109 |
|
|
2021
Q4 | $5.44M | Sell |
61,523
-6,502
| -10% | -$574K | 0.19% | 102 |
|
|
2021
Q3 | $5.26M | Sell |
68,025
-4,466
| -6% | -$345K | 0.19% | 93 |
|
|
2021
Q2 | $6.05M | Sell |
72,491
-14
| -0% | -$1.17K | 0.22% | 85 |
|
|
2021
Q1 | $5.48M | Sell |
72,505
-3,243
| -4% | -$245K | 0.18% | 105 |
|
|
2020
Q4 | $6.64M | Sell |
75,748
-5,125
| -6% | -$449K | 0.23% | 81 |
|
|
2020
Q3 | $6.15M | Buy |
80,873
+9,991
| +14% | +$760K | 0.25% | 83 |
|
|
2020
Q2 | $8.74M | Sell |
70,882
-1,056
| -1% | -$130K | 0.38% | 70 |
|
|
2020
Q1 | $6.08M | Sell |
71,938
-491
| -0.7% | -$41.5K | 0.34% | 85 |
|
|
2019
Q4 | $6.12M | Buy |
72,429
+6,763
| +10% | +$572K | 0.21% | 118 |
|
|
2019
Q3 | $4.43M | Sell |
65,666
-685
| -1% | -$46.2K | 0.16% | 122 |
|
|
2019
Q2 | $5.68M | Sell |
66,351
-12,366
| -16% | -$1.06M | 0.19% | 125 |
|
|
2019
Q1 | $6.99M | Buy |
78,717
+9,637
| +14% | +$856K | 0.23% | 120 |
|
|
2018
Q4 | $5.88M | Buy |
69,080
+16,609
| +32% | +$1.41M | 0.21% | 116 |
|
|
2018
Q3 | $5.09M | Buy |
52,471
+1,197
| +2% | +$116K | 0.18% | 117 |
|
|
2018
Q2 | $4.83M | Buy |
51,274
+8,913
| +21% | +$840K | 0.18% | 124 |
|
|
2018
Q1 | $3.43M | Buy |
42,361
+1,285
| +3% | +$104K | 0.13% | 121 |
|
|
2017
Q4 | $3.66M | Buy |
41,076
+32,371
| +372% | +$2.89M | 0.14% | 119 |
|
|
2017
Q3 | $810K | Sell |
8,705
-1,065
| -11% | -$99.1K | 0.04% | 249 |
|
|
2017
Q2 | $887K | Buy |
9,770
+929
| +11% | +$84.3K | 0.04% | 247 |
|
|
2017
Q1 | $776K | Buy |
8,841
+253
| +3% | +$22.2K | 0.04% | 254 |
|
|
2016
Q4 | $711K | Buy |
+8,588
| New | +$711K | 0.04% | 254 |
|
|
2016
Q1 | – | Sell |
-2,045
| Closed | -$214K | – | 297 |
|
|
2015
Q4 | $214K | Buy |
+2,045
| New | +$214K | 0.01% | 293 |
|